» Articles » PMID: 33231691

Barriers, Facilitators, and Interventions for Medication Adherence Across Chronic Conditions with the Highest Non-adherence Rates: a Scoping Review with Recommendations for Intervention Development

Overview
Date 2020 Nov 24
PMID 33231691
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Medication non-adherence (MNA) constitutes a complex health problem contributing to increased economic burden and poor health outcomes. The Medication Adherence Model (MAM) supports that numerous processes are involved in medication adherence (MA). Based on the MAM and guidelines of the World Health Organization (WHO), this scoping review aimed to identify the barriers and facilitators associated with MA, and the behavioral health interventions and techniques among chronic conditions presenting with high non-adherence rates (asthma, cancer, diabetes, epilepsy, HIV/AIDS, and hypertension). PubMed, PsycINFO, and Scopus databases were screened, and 243 studies were included. A mixed methods approach was used to collate the evidence and interpret findings. The most commonly reported barriers to MA across conditions were younger age, low education, low income, high medication cost, side effects, patient beliefs/perceptions, comorbidities, and poor patient-provider communication. Additionally, digitally delivered interventions including components such as medication and condition education, motivational interviewing (MI), and reinforcement and motivational messages led to improvements in MA. This review highlights the importance of administrating multicomponent interventions digitally and personalized to the patients' individual needs and characteristics, responding to the adherence barriers faced. This is the first review examining and synthesizing evidence on barriers and facilitators to MA and behavioral health interventions used for improving MA across chronic conditions with the highest non-adherence rates and providing recommendations to researchers and clinicians. Stakeholders are called to explore methods overcoming barriers identified and developing effective multicomponent interventions that can reduce the high rates of MNA.

Citing Articles

Implementing motivational interviewing to improve endocrine therapy adherence among breast cancer patients: a qualitative process evaluation of the getset pilot intervention.

Dunsmore V, Ellis C, Drier S, Waters A, Fray N, Stylianou C Cancer Causes Control. 2025; .

PMID: 39979769 DOI: 10.1007/s10552-025-01971-y.


Trust in nurses and its association with medication adherence of cardiovascular patients: A descriptive correlational study.

Aliafsari Mamaghani E, Soleimani A, Zirak M Int J Nurs Stud Adv. 2025; 8:100278.

PMID: 39759401 PMC: 11697126. DOI: 10.1016/j.ijnsa.2024.100278.


Time toxicity in cancer care: A concept analysis using Walker and Avant's method.

Nwozichi C, Omolabake S, Ojewale M, Faremi F, Brotobor D, Olaogun E Asia Pac J Oncol Nurs. 2024; 11(12):100610.

PMID: 39641009 PMC: 11617379. DOI: 10.1016/j.apjon.2024.100610.


Medication adherence in geriatric patients attending medical outpatient department.

Odubanjo O, Tipping B, Greenstein L S Afr Fam Pract (2004). 2024; 66(1):e1-e8.

PMID: 39494658 PMC: 11538091. DOI: 10.4102/safp.v66i1.6011.


The contribution of Specialist Family Physicians to South Africa's private sector: A position statement.

Ashford G, Mathew S, Fray G, Irinoye I, Ross A, Von Pressentin K S Afr Fam Pract (2004). 2024; 66(1):e1-e2.

PMID: 39354786 PMC: 11538079. DOI: 10.4102/safp.v66i1.6022.